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ABSTRACT
Objective To examine the social determinants of influenza 
and pertussis vaccine uptake among pregnant women in 
England.
Design Nationwide population- based cohort study.
Setting The study used anonymised primary care data 
from the Clinical Practice Research Datalink and linked 
Hospital Episode Statistics secondary care data.
Participants Pregnant women eligible for pertussis 
(2012–2015, n=68 090) or influenza (2010/2011–
2015/2016, n=152 132) vaccination in England.
Main outcome measures Influenza and pertussis 
vaccine uptake.
Results Vaccine uptake was 67.3% for pertussis and 39.1% 
for influenza. Uptake of both vaccines varied by region, with the 
lowest uptakes in London and the North East. Lower vaccine 
uptake was associated with greater deprivation: almost 10% 
lower in the most deprived quintiles compared with the least 
deprived for influenza (34.5% vs 44.0%), and almost 20% 
lower for pertussis (57.7% vs 76.0%). Lower uptake for both 
vaccines was also associated with non- white ethnicity (lowest 
among women of black ethnicity), maternal age under 20 
years and a greater number of children in the household. The 
associations between all social factors and vaccine uptake 
were broadly unchanged in fully adjusted models, suggesting 
the social determinants of uptake were largely independent of 
one another. Among 3111 women vaccinated against pertussis 
in their first eligible pregnancy and pregnant again, 1234 (40%) 
were not vaccinated in their second eligible pregnancy.
Conclusions Targeting promotional campaigns to 
pregnant women who are younger, of non- white ethnicity, 
with more children, living in areas of greater deprivation or 
the London or North East regions, has potential to reduce 
vaccine- preventable disease among infants and pregnant 
women, and to reduce health inequalities. Vaccination 
promotion needs to be sustained across successive 
pregnancies. Further research is needed into whether the 
effectiveness of vaccine promotion strategies may vary 
according to social factors.
INTRODUCTION
Pertussis (whooping cough) and seasonal 
influenza are vaccine- preventable diseases. 
Influenza can have severe outcomes among 
pregnant women and young infants, including 
hospitalisation and death.1 Pertussis can be a 
serious illness for young infants: a pertussis 
outbreak in 2012 resulted in 14 infant deaths, 
most of whom were too young to be vacci-
nated directly.2–4 Vaccination in pregnancy 
reduces influenza- associated hospitalisation 
among pregnant women,5 and provides 
‘passive immunity’ to protect infants in the 
first months of life.6 7 In England, pertussis 
vaccination has been offered to women in 
later stages of pregnancy since 2012 and 
seasonal influenza vaccination at any stage 
of pregnancy during influenza season since 
2010, with both provided free of charge.2 8
Low vaccine uptake during pregnancy is 
a major public health challenge for high- 
income countries.9 According to routine 
surveillance in 2018/2019, vaccine uptake 
among pregnant women in England was 
68.8% for pertussis and 45.2% for influ-
enza.10 11 Although comparatively high for a 
high- income country, this suboptimal uptake 
still limits the programme’s impact and results 
Strengths and limitations of this study
 ► This large cohort study explored the social determi-
nants of influenza and pertussis vaccination among 
pregnant women across England. It considered a 
range of social determinants including maternal age, 
ethnicity, socioeconomic status, number of children 
in the household and region.
 ► The Clinical Practice Research Datalink/London 
School of Hygiene and Tropical Medicine Pregnancy 
Register was used to ascertain pregnancies and 
their timing from primary care records using de-
tailed algorithms.
 ► We were unable to investigate other potential social 
determinants of uptake not routinely recorded in 
primary care records such as education or religion.
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in vaccine- preventable deaths among infants of unvac-
cinated mothers. Studies of determinants of maternal 
influenza vaccine uptake to date have largely focused on 
health beliefs.12 Studies in the USA have found inequali-
ties in vaccine uptake during pregnancy by ethnicity/race, 
age and insurance status.13–15 Less is known about the 
role of social factors in England. During the 2009 influ-
enza pandemic, higher vaccine uptake in pregnancy was 
associated with higher maternal age, previous deliveries 
and underlying health conditions but not deprivation.16 
However, ecological studies suggest that both seasonal 
influenza and pertussis vaccine uptake in pregnancy 
vary with ethnicity, and are lower in areas with greater 
deprivation, and are thus sources of health inequalities 
in infancy.17 18 Smaller studies of pertussis and seasonal 
influenza vaccines have suggested deprivation, ethnicity, 
maternal age and parity or number of children may be 
factors in maternal vaccine uptake, but have lacked power 
to describe these associations fully.19–23 A better under-
standing of the social determinants of maternal vaccine 
uptake could inform targeted public health interventions 
to improve vaccine uptake and reduce health inequalities.
This study aimed to use linked electronic health 
records to examine the social determinants of influenza 
and pertussis vaccine uptake among pregnant women in 
England for the first few years from programme introduc-




This historical cohort study used data from the Clinical 
Practice Research Datalink (CPRD), a quality- assured 
anonymised primary care patient dataset covering 
approximately 7% of general practices in England, a 
representative sample of the population by age and 
sex.24 25 Available data include diagnoses and symptoms, 
prescriptions, immunisations and referrals recorded in 
primary care. The CPRD/London School of Hygiene 
and Tropical Medicine (LSHTM) Pregnancy Register 
details all pregnancies recorded in primary care, identi-
fied using detailed algorithms to determine their timing 
and outcomes.26 The Pregnancy Register has been found 
to have a high sensitivity for livebirths (including 90% of 
all deliveries recorded in secondary care) but may under- 
record pregnancies which end in a loss.26 27 For this 
analysis, we used the Pregnancy Register and CPRD data 
prelinked to Hospital Episode Statistics (HES) admissions 
data (for supplementary ethnicity data),28 and Office of 
National Statistics (ONS) small- area- level deprivation 
data.29
Study population
Analysis of pertussis vaccine and seasonal influenza 
vaccine uptake were conducted separately. For each 
vaccine, we identified pregnancies eligible for the relevant 
vaccination among women registered with CPRD, using 
the Pregnancy Register to identify start and end dates of 
pregnancies, eligible dates based on gestation, and preg-
nancy outcomes. Eligible women were registered at one 
of the 75% of CPRD practices in England which partici-
pate in the CPRD data- linkage scheme, for availability of 
linked HES and ONS data.24 Vaccine eligibility started on 
or after 1 October 2012 for the pertussis vaccine analyses, 
and on or after 1 April 2010 for the seasonal influenza 
vaccine analyses, reflecting the introduction of vaccina-
tion programmes.2 8 For each vaccine, the first eligible 
pregnancy for each woman during the follow- up period 
was used to avoid non- independence in the data.
Vaccination guidelines during the study period 
suggested women should be offered pertussis vaccination 
in their third trimester of pregnancy (ideally between 
28 and 32 weeks, though it could be offered between 28 
and 38 weeks’ gestation).2 For the pertussis vaccine anal-
yses, we included women who delivered a live or stillborn 
child on or after 26 weeks of pregnancy and followed 
up for vaccination up to 40 weeks’ gestation, which 
allowed for up to 2 weeks imprecision in the Pregnancy 
Register estimation of the vaccine eligible period and 
mirrored the national surveillance approach. The study 
period ended before the April 2016 change in guidelines 
recommending vaccination at 16–32 weeks of pregnancy 
(though it may be given up to delivery), and changes in 
the commissioning arrangements leading to increased 
delivery through maternity services from 2016.2
Influenza vaccination is recommended at any stage in 
pregnancy that overlaps with the influenza season.8 For 
the influenza vaccine analyses, all pregnancies for which 
the Pregnancy Register included a known outcome (such 
as stillbirth, live birth, miscarriage or termination) were 
included, irrespective of duration of pregnancy, providing 
the pregnancy overlapped by at least 1 day with the influ-
enza season (1 September to 31 January of each year).
We limited primary analyses for both maternal vaccines 
to women who registered as patients at the primary care 
practice by the end of their first trimester, to reduce 
misclassification of vaccination status. We conducted 
sensitivity analyses around the study inclusion criteria, 
which are described later.
Follow-up period
The study period ranged from 1 October 2012 to 30 
September 2015 for pertussis vaccine and 1 September 
2010 to 31 January 2016 for influenza vaccine. Start of 
follow- up was considered the latest date of: start of the 
study period, practice meeting CPRD quality standards, 
patient registration at the practice, 11th birthday (dates 
of birth based on the mid- point of year of birth), 26 
weeks’ gestation of pregnancy (for pertussis), the start of 
pregnancy plus 2 weeks (for influenza) or 1 September 
of each year (for influenza). End of follow- up was the 
earliest date of: last data collection from the practice, end 
of linkage to HES, patient transfer out of the practice, 
49th birthday, death, receipt of the vaccine of interest, the 
40th week of pregnancy (for pertussis), end of pregnancy 
3Walker JL, et al. BMJ Open 2021;11:e046545. doi:10.1136/bmjopen-2020-046545
Open access
(for influenza), end of the study period or 31 January of 
each year (for influenza).
Vaccine uptake
Vaccination status for both maternal pertussis and influ-
enza vaccines was extracted from CPRD. For the primary 
analysis of pertussis vaccine uptake, women were consid-
ered vaccinated if they received the vaccine between 26 
and 40 weeks of pregnancy gestation, which is similar to 
the national vaccination guidelines of 28–38 weeks but 
allows for up to 2 weeks discrepancy in the Pregnancy 
Register estimation of gestation. Women who were not 
vaccinated between 26 and 40 weeks of gestation were 
considered unvaccinated, irrespective of vaccination 
before 26 weeks or after 40 weeks of gestation. For the 
primary analysis of influenza vaccine uptake, women were 
considered vaccinated if they received the vaccine on any 
day between 1 September and 31 January during their 
follow- up period. Women with a pregnancy that spanned 
two influenza seasons (n=19 963, 14%) were counted in 
the denominator of the latter season and considered 
vaccinated if vaccinated in either season.
Social characteristics and clinical conditions
We defined social determinants using previously 
published detailed algorithms.30 Index of multiple depri-
vation (IMD, a composite measure of relative depriva-
tion) was assigned in quintiles (quintile one representing 
least deprived, quintile five most deprived) based on the 
Lower Super Output Area of the patient’s residential 
address using ONS data.29 Ethnicity (white, South Asian, 
black, mixed, other) was defined using primary care 
records supplemented with linked HES data.28 Other 
social factors of interest were defined using CPRD primary 
care data and comprised: region of residence (London, 
North East, North West, Yorkshire and The Humber, 
East Midlands, West Midlands, East of England, South 
West, South Central and South East Coast), maternal age 
(based on midpoint of year of birth) and number of chil-
dren in the household.
For influenza vaccine uptake analyses, whether the 
individual was in a clinical risk group indicated to receive 
influenza vaccine was defined according to national guid-
ance,8 and comprised the following conditions: chronic 
renal disease, chronic heart disease, chronic respiratory 
disease, chronic liver disease, diabetes, immunosuppres-
sion, chronic neurological disease, asplenia and morbid 
obesity. Clinical risk groups were identified using Read 
codes, primary care prescription records (for immuno-
suppression and asthma), and height and weight records. 
Body mass index (BMI) was defined using height and 
weight records using validated methods,31 and defined 
based on the record closest to the beginning of pregnancy, 
allowing measures during the first trimester of pregnancy. 
Asthma was defined as an asthma diagnosis and either any 
history of an emergency hospital admission for asthma, or 
any inhaled or oral steroid prescription in the previous 12 
months. The algorithms used for immunosuppression are 
described in previous studies32; codelists for other condi-
tions are available online (https://doiorg/1017037/
DATA00001907).
Statistical analysis
Parallel analyses were conducted for pertussis and influ-
enza vaccine uptake. For each vaccine, a complete case 
analysis (excluding women with no ethnicity recorded in 
the main analysis) using multivariable logistic regression 
was used to estimate associations between vaccine uptake 
and social determinants. Our modelling strategy followed 
a previously adapted version33 of a conceptual framework 
to analyse the hierarchical inter- relationships between 
distal and proximate social determinants with vaccine 
uptake (online supplemental file 1).34 We first fitted 
a ‘minimally adjusted’ model to estimate associations 
between each social determinant and vaccine uptake 
adjusted for year (calendar year for pertussis, financial 
year for influenza to reflect the influenza season) to 
adjust for secular trends as an a priori confounder. We 
then fitted five further sequential models. Models 1–3 
explored the social determinants of uptake from distal 
to proximal. Model 4 and the BMI model explored the 
extent to which these were mediated by clinical condi-
tions (for influenza), and mediated and/or confounded 
by BMI (for both vaccines).
In model 1 we assessed associations between vaccine 
uptake and the distal determinants IMD, region and 
ethnicity, mutually adjusted and adjusted for year. In 
model 2 the intermediate variable maternal age was 
added alongside the variables in model 1 to determine 
to what extent this explained any effect of the distal vari-
ables. Model 3 comprised the variables in model 2 and 
the proximate variable number of children, to investi-
gate whether this mediated the effect of the distal and 
intermediate variables. For influenza uptake modelling, 
we further added clinical risk group as a potential medi-
ator of the social characteristics (model 4). Finally, we 
repeated complete case analyses additionally excluding 
women with no recorded BMI for all four models, adding 
a further model (BMI model) that additionally adjusted 
for BMI, which may both mediate and confound the 
effect of social characteristics and clinical conditions.
All analyses were conducted using Stata V.15 
(StataCorp).
Missing data and sensitivity analyses
Primary analyses were conducted on women who had non- 
missing ethnicity and who were registered with an up- to- 
standard CPRD practice by the end of their first trimester. 
Other than ethnicity, only BMI had missing data.
We performed descriptive and sensitivity analyses to 
understand how estimates of vaccine uptake and asso-
ciations with social determinants might be affected by 
missing data or study inclusion criteria. First, we exam-
ined the distribution of social determinants among 
women with and without recorded ethnicity. Second, we 
compared estimates from minimally and fully adjusted 
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models from the primary analyses with sensitivity analyses 
including women who registered with an up- to- standard 
practice by the end of pregnancy (instead of end of first 
trimester) for both vaccines. For the pertussis analyses, 
we further ran minimally and fully adjusted models that 
mirrored national surveillance criteria of immunisation 
at 28–38 weeks’ gestation, to assess the impact of allowing 
a 2- week window for imprecise estimation of gestation in 
our primary analysis. For the influenza analyses, we further 
ran models that included pregnancies with no recorded 
outcome, as well as models that extended the influenza 
season through 31 March of each year. Finally, for both 
pertussis and influenza analyses, we fitted random effects 
models to test for clustering by general practice.
Secondary analysis of sequential pregnancies
In response to the finding that vaccine uptake declined 
with greater number of children in the household, a 
post- hoc secondary analysis was added investigating 
the social determinants associated with vaccination in 
a second eligible pregnancy among women who had 
received pertussis vaccination in their first eligible preg-
nancy. This analysis focused on pertussis vaccination, as 
influenza vaccination uptake may depend on the extent 
and timing of the overlap of pregnancy with the influ-
enza season, severity of the influenza season and timing 
of vaccine availability, reducing the number of eligible 
sequential pregnancies and increasing the complexity 
of external factors which may affect a women’s vaccine 
uptake across sequential pregnancies. Logistic regression 
with likelihood ratio tests were used to model and test 
minimally adjusted and fully adjusted (model 3) associ-
ations between the outcome (vaccination in the second 
eligible pregnancy) and social determinants measured at 
baseline of the first eligible pregnancy, as well as addition-
ally adjusting for the time interval between the end of the 
first pregnancy and the start of the next.
RESULTS
Sample characteristics
A total of 68 090 women from 402 general practices 
were eligible for the pertussis vaccine analysis, and 
1 52 132 women from 456 general practices were eligible 
for the influenza vaccine analysis during the study period 
(2012–2015 for pertussis and 2010/2011–2015/2016 for 
influenza). Many women were eligible to be offered both 
pertussis and influenza vaccinations during the study: 
66 143 women were included in both analytic samples 
(97.1% of the pertussis vaccine cohort and 43.5% of the 
influenza cohort). There were 5553 (8.9%) and 11 991 
(7.9%) women from the pertussis and influenza vaccine 
analyses, respectively, who had missing ethnicity and were 
excluded from analysis.
Compared with women with recorded ethnicity, 
women with missing ethnicity were more likely to have 
an eligible pregnancy later in the study period, reside in 
South Central or South East Coast regions of England, 
have no children living in their household and to have 
missing BMI information. Vaccine uptake was similar 
between women with recorded versus missing ethnicity 
for pertussis (67.3% vs 68.2) and influenza (39.1% vs 
40.4%) (all p<0.001, online supplemental file 1).
Primary analyses: pertussis vaccination
Among 62 537 eligible women with recorded ethnicity, 
maternal pertussis vaccine uptake increased each year, 
reaching 71.7% in 2015 (table 1). Uptake was also highest 
in the least deprived areas (76.0%, figure 1) and East and 
West Midlands (74.5% and 72.9%, respectively), and 
among women of white ethnicity (69.0%), aged 30–35 
years (70.8%), who had no other children living in house-
hold (74.4%), who were of normal weight or overweight 
(69.2% and 69.3%, respectively).
After adjusting for calendar year, those who resided 
in the most deprived areas had less than half the odds 
of vaccine uptake compared with those in the least 
deprived areas, and those in all regions of England 
apart from the North East had increased odds of uptake 
compared with London (table 1). Pertussis vaccina-
tion uptake was appreciably lower among all non- white 
ethnic groups, with reduced odds of between 24% 
(South Asian) and 55% (black ethnicity) compared 
with those of white ethnicity. The odds of vaccination 
increased non- linearly with maternal age; compared 
with women aged 20–24 years, women who were <20 
years had 21% lower odds of receiving vaccination 
and there was an increased likelihood of vaccination 
among women aged ≥25 years, reaching 54% increased 
odds of uptake among those aged 30–35 years. Uptake 
decreased linearly with increasing numbers of children 
living in the household; 33% less likely among women 
with one child, 53% less likely among women with two 
children and 65% less likely among women with three 
or more children (table 1). Among the 55 871 women 
with available BMI data, calendar- year adjusted uptake 
was 29% less likely among women whose BMI was classi-
fied as underweight and 18% less likely among women 
classified as obese, compared with women with normal 
BMI (table 1).
Associations in the minimally adjusted models were 
largely unchanged after additionally adjusting for IMD, 
region and ethnicity (model 1), maternal age (model 2) 
and number of children (model 3). Associations were 
slightly attenuated (>10% change) for some regions in 
England (ie, East of England, South Central and South 
East Coast) in model 1 and model 2, but not in model 
3. Similarly, associations of pertussis uptake were margin-
ally attenuated in non- white ethnic groups by adjustment 
for IMD and region (model 2). However, strong evidence 
of all these associations remained. Model estimates were 
also robust to the additional adjustment for BMI in the 
subset of women with non- missing BMI (online supple-
mental file 1).
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for year ‘minimally 
adjusted’ OR (95% CI)
Model 1 additionally 
adjusted for IMD, 





maternal age OR 
(95% CI)
Model 3 additionally 
adjusted for number 
of children ‘fully 
adjusted’ OR (95% 
CI)
Year
  2012 6717 (10.7) 3809 (56.7) 1 1 1 1
  2013 24 657 (39.4) 16 749 (67.9) 1.62 (1.53 to 1.71) 1.66 (1.57 to 1.75) 1.66 (1.57 to 1.75) 1.69 (1.60 to 1.79)
  2014 20 148 (32.2) 13 638 (67.7) 1.60 (1.51 to 1.69) 1.63 (1.54 to 1.73) 1.63 (1.54 to 1.73) 1.66 (1.57 to 1.76)
  2015 11 015 (17.6) 7903 (71.7) 1.94 (1.82 to 2.07) 2.00 (1.87 to 2.13) 2.00 (1.87 to 2.13) 2.03 (1.90 to 2.17)
Index of multiple deprivation (IMD) quintile
  Least deprived 13 285 (21.2) 10 090 (76.0) 1 1 1 1
  2 11 335 (18.1) 8064 (71.1) 0.78 (0.74 to 0.83) 0.79 (0.74 to 0.83) 0.80 (0.75 to 0.85) 0.81 (0.76 to 0.86)
  3 12 933 (20.7) 8807 (68.1) 0.68 (0.64 to 0.71) 0.68 (0.64 to 0.72) 0.70 (0.66 to 0.74) 0.73 (0.69 to 0.77)
  4 12 973 (20.7) 8205 (63.2) 0.54 (0.52 to 0.57) 0.56 (0.53 to 0.59) 0.59 (0.56 to 0.62) 0.64 (0.60 to 0.67)
  Most deprived 12 011 (19.2) 6933 (57.7) 0.43 (0.41 to 0.46) 0.45 (0.42 to 0.47) 0.48 (0.45 to 0.51) 0.54 (0.51 to 0.57)
Region
  London 11 894 (19.0) 7239 (60.9) 1 1 1 1
  North East 1185 (1.9) 687 (58.0) 0.91 (0.81 to 1.03) 0.96 (0.85 to 1.09) 1.00 (0.88 to 1.13) 1.04 (0.92 to 1.19)
  North West 8835 (14.1) 5873 (66.5) 1.29 (1.22 to 1.36) 1.28 (1.20 to 1.35) 1.30 (1.22 to 1.38) 1.36 (1.27 to 1.44)
  Yorkshire and 
The Humber
1000 (1.6) 699 (69.9) 1.51 (1.31 to 1.74) 1.46 (1.27 to 1.69) 1.51 (1.30 to 1.74) 1.54 (1.33 to 1.79)
  East Midlands 326 (0.5) 243 (74.5) 2.18 (1.69 to 2.81) 2.24 (1.73 to 2.90) 2.30 (1.78 to 2.98) 2.38 (1.84 to 3.09)
  West Midlands 7050 (11.3) 5046 (71.6) 1.64 (1.54 to 1.75) 1.58 (1.48 to 1.69) 1.62 (1.52 to 1.73) 1.72 (1.61 to 1.84)
  East of England 5568 (8.9) 4058 (72.9) 1.75 (1.63 to 1.88) 1.50 (1.40 to 1.61) 1.52 (1.41 to 1.63) 1.57 (1.46 to 1.69)
  South West 7002 (11.2) 4800 (68.6) 1.43 (1.34 to 1.52) 1.32 (1.24 to 1.41) 1.35 (1.26 to 1.44) 1.43 (1.33 to 1.52)
  South Central 10 381 (16.6) 7185 (69.2) 1.45 (1.37 to 1.53) 1.19 (1.12 to 1.26) 1.21 (1.15 to 1.29) 1.28 (1.21 to 1.36)
  South East 
Coast
9296 (14.9) 6269 (67.4) 1.33 (1.26 to 1.41) 1.10 (1.04 to 1.17) 1.12 (1.06 to 1.19) 1.19 (1.12 to 1.26)
Ethnicity
  White 52 598 (84.1) 36 272 (69.0) 1 1 1 1
  South Asian 4692 (7.5) 2951 (62.9) 0.76 (0.71 to 0.81) 0.83 (0.78 to 0.88) 0.79 (0.74 to 0.85) 0.83 (0.78 to 0.88)
  Black 2583 (4.1) 1294 (50.1) 0.45 (0.41 to 0.48) 0.58 (0.54 to 0.64) 0.56 (0.52 to 0.61) 0.61 (0.56 to 0.67)
  Mixed 922 (1.5) 549 (59.5) 0.65 (0.57 to 0.74) 0.72 (0.63 to 0.82) 0.71 (0.62 to 0.82) 0.72 (0.63 to 0.83)
  Other 1742 (2.8) 1033 (59.3) 0.65 (0.59 to 0.72) 0.73 (0.66 to 0.80) 0.70 (0.63 to 0.77) 0.68 (0.62 to 0.75)
Maternal age, years
  <20 2079 (3.3) 1153 (55.5) 0.79 (0.72 to 0.87) 0.80 (0.73 to 0.89) 0.81 (0.73 to 0.89)
  20–24 8848 (14.1) 5416 (61.2) 1 1 1
  25–29 16 696 (26.7) 11 166 (66.9) 1.27 (1.21 to 1.34) 1.24 (1.18 to 1.31) 1.29 (1.22 to 1.36)
  30–35 20 294 (32.5) 14 376 (70.8) 1.54 (1.46 to 1.62) 1.43 (1.35 to 1.51) 1.55 (1.47 to 1.64)
  ≥35 14 620 (23.4) 9988 (68.3) 1.36 (1.29 to 1.44) 1.25 (1.18 to 1.32) 1.42 (1.34 to 1.51)
Number of children
  0 26 622 (42.6) 19 814 (74.4) 1 1
  1 22 132 (35.4) 14 673 (66.3) 0.67 (0.65 to 0.70) 0.65 (0.63 to 0.68)
  2 8645 (13.8) 5009 (57.9) 0.47 (0.45 to 0.49) 0.47 (0.45 to 0.50)
  ≥3 5138 (8.2) 2603 (50.7) 0.35 (0.33 to 0.37) 0.37 (0.35 to 0.40)
Body mass index (BMI)
  <18.5 
underweight
2063 (3.3) 1265 (61.3) 0.71 (0.64 to 0.77)
  18.5–24.9 29 045 (46.4) 20 095 (69.2) 1
  25.0–29.9 
overweight
14 211 (22.7) 9852 (69.3) 1.01 (0.96 to 1.05)
Continued
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Primary analyses: influenza vaccination
Similar to pertussis vaccination, maternal influenza 
vaccine uptake was highest (46%) by the end of the 
study period (the 2015/2016 season) among the 140 141 
eligible women with recorded ethnicity (table 2). Uptake 
was also highest in the least deprived areas (44.0%, 
figure 1), in the South Central and West Midlands regions 
(42.6% and 42.2%, respectively), and among women of 
white ethnicity (39.8%), aged 30–35 years (41.0%), who 
had no children living in household (43.0%) and who 
were overweight (40.4%). Influenza vaccination uptake 
was lowest among women of black ethnicity, with 16% 
reduced odds of uptake compared with those of White 
ethnicity. Women who were classified as being in a clin-
ical risk group had the highest influenza vaccine uptake 
(50.9%) out of all subgroups.
Findings of associations between social determinants 
and influenza vaccine uptake were largely the same as 
those with pertussis uptake (table 2). Women were 65% 
more likely to receive the influenza vaccination in the 
2015/2016 season compared with the 2010/2011 season. 
Similarly, in influenza- season adjusted models, women 
who resided in the most deprived areas had 29% lower 
odds of receiving vaccination, and women in all regions 
outside of London were more likely to be vaccinated. 
Associations with ethnicity, maternal age, number of chil-
dren and BMI also mirrored those found in the pertussis 
uptake models, although the lower uptake seen with 
women of non- white ethnicity was less marked than that 
seen for pertussis vaccination. Women identified as being 
in a clinical risk group for influenza were 69% more likely 
to be vaccinated than those not in a clinical risk group. 
Associations were robust throughout all subsequent 
models except for South Asian ethnicity and South East 
Coast regional residence, and remained after additional 
adjustment for clinical risk group in model 4 (table 2). 
Model estimates were also robust to the additional adjust-
ment for BMI in the model excluding those with missing 
BMI (online supplemental file 1).
Sensitivity analyses
Directions of associations and conclusions were robust 
to all sensitivity analysis for pertussis vaccination (online 
supplemental file 1) and influenza vaccination (online 
supplemental file 1), and we found no evidence of clus-
tering at the practice level in the primary analysis models 
for either pertussis or influenza uptake (p=0.07, 95% CI 
0.06 to 0.09 for pertussis, p=0.03, 95% CI 0.03 to 0.03 for 
influenza).
Secondary analysis
Among women who were included in the main study, 
there were 3111 women who received pertussis vaccina-
tion in their first eligible pregnancy and who completed 
a second eligible pregnancy within the study period. 
Among these, 1234 (39.7%) were not vaccinated in their 
second eligible pregnancy. Social determinants of vaccine 
uptake among women who had previously received vacci-
nation in pregnancy were similar to those in the main 
analysis, with lower uptake in the second eligible preg-
nancy associated with younger maternal age at the first 
pregnancy, a greater number of children in the house-
hold and a longer interval between pregnancies (online 
supplemental file 1).
DISCUSSION
Vaccine uptake in pregnancy over the study period was 
67.3% for pertussis and 39.1% for influenza. Lower 
vaccine uptake was associated with greater deprivation: 
the gap in uptake between the least and most deprived 
quintiles was almost 10% for influenza, and almost 20% 
for pertussis. Lower uptake was also associated with non- 
white ethnicity (particularly black ethnicity), maternal 







for year ‘minimally 
adjusted’ OR (95% CI)
Model 1 additionally 
adjusted for IMD, 





maternal age OR 
(95% CI)
Model 3 additionally 
adjusted for number 
of children ‘fully 
adjusted’ OR (95% 
CI)
  ≥30 obese 10 552 (16.9) 6833 (64.8) 0.82 (0.78 to 0.86)
  Missing 6666 (10.7) 4054 (60.8)
N=62 537 from 402 practices. Overall vaccine uptake 42 099 (67.3%).
All models include women who registered before the end of the first trimester and delivered a live or stillborn child on or after 26 weeks of pregnancy and exclude 
those with missing ethnicity; minimally adjusted model of BMI additionally excludes 6666 women with missing BMI.
Table 1 Continued
Figure 1 Unadjusted pertussis and influenza vaccine 
coverage in pregnancy, by deprivation.
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the household. The associations between all social factors 
and vaccine uptake were largely independent of one 
another. Among women eligible for pertussis vaccination 
in two pregnancies and vaccinated in the first, 40% were 
not vaccinated in their second eligible pregnancy.
To our knowledge, this is the first large study of fully 
individual- level social determinants of maternal vaccine 
uptake of seasonal influenza and pertussis in England. 
Our findings differ from a large national study which 
found no association between deprivation and pandemic 
influenza vaccine uptake in pregnancy (although vaccine 
uptake did increase with maternal age) but the previous 
study was in the context of the 2010 influenza pandemic.16 
Both the overall uptakes and the patterns of regional vari-
ation are consistent with national surveillance and ecolog-
ical studies. Lower vaccine uptake in London is seen 
more widely across the vaccination programme.10 11 17 18 
For influenza vaccine, the denominator may be seen as 
overinclusive as some women may have only a short time 
period eligible for vaccination (due to pregnancy loss 
or limited overlap of pregnancy with influenza season), 
resulting in a low estimate of uptake. For seasonal influ-
enza and pertussis vaccines, previous studies have gener-
ally suggested associations consistent with those we 
observed for deprivation, ethnicity, maternal age and 
parity or number of children, but studies have been 
ecological or pseudo- individualised, or were underpow-
ered for precise estimates.17–21 23 Our findings in a large 
and nationally representative dataset demonstrate that 
each of these factors is an independent individual- level 
determinant of maternal vaccine uptake, outside of a 
pandemic context.
The novel finding that 40% of women who had been 
vaccinated in their first eligible pregnancy were not in 
their second is surprising, and suggests that low vaccine 
uptake in pregnancy is not fully determined by fixed 
maternal attitudes to vaccination, but may reflect health-
care access or awareness of the need for vaccination in 
each pregnancy.
Strengths of this study include the use of the CPRD/
LSHTM Pregnancy Register with linked hospital and 
mortality data and detailed algorithms to identify preg-
nancy timings and a range of individual- level social deter-
minants among a nationally representative population.30
Key limitations include low representation from some 
regions (in particular the East Midlands), and that not 
all potentially relevant social factors were available, such 
as education and religion. We may have over- estimated 
vaccine uptake as the pregnancy register may not include 
all pregnancies which ended in a loss without coming to 
the attention of healthcare workers. We included only 
timely pertussis vaccinations (before 40 weeks’ gestation) 
which may result in lower uptake estimates than pertussis 
vaccine uptake by delivery. Our study was also limited 
to vaccination recorded in primary care records, which 
could have resulted in some under- recording of influ-
enza vaccination, although maternity- led vaccination 
services were rare before 2016, and general practitioners 
are required to document vaccinations given outside the 
surgery. To minimise misclassification, we ended our 
study period prior to the introduction of pertussis vacci-
nation in antenatal settings.
The large differences we observed in vaccine uptake 
by deprivation and ethnicity indicate a key opportunity 
to reduce health inequalities. Targeting interventions 
and improving access to vaccines through primary care 
and maternity services for pregnant women who live in 
more deprived areas, are of non- white ethnicity, younger, 
or have more children may reduce health inequalities, 
improve overall vaccine uptake and reduce vaccine- 
preventable deaths among women and children. In addi-
tion to targeted vaccination promotion, wider action is 
needed to address inequalities in access to timely ante-
natal care.35 The drop- off in uptake in second pregnan-
cies suggests a need for awareness- raising of the rationale 
for passive immunisation of infants and the need for vacci-
nation in each pregnancy. Communications to empha-
sise the need for vaccination in every pregnancy should 
be available in a range of locally appropriate languages. 
Since 2016, pertussis vaccination has been available in 
maternity services, aiming to increase opportunities for 
vaccine uptake, and it will be important to ensure that 
healthcare worker training also captures the importance 
of vaccination in every pregnancy and to monitor the 
impact of delivery in alternative settings on inequalities 
in uptake.
Our study adds to international evidence of health 
inequalities in vaccination uptake in high- income coun-
tries. Studies in the USA have found inequalities in 
vaccine uptake by insurance type, race/ethnicity and 
education.13–15 Our finding of large inequalities in 
vaccine uptake during pregnancy in England, despite 
universal healthcare which is free at the point of access, 
highlights the need for other high- income countries to 
investigate and address inequalities in vaccine uptake 
during pregnancy.
Further research is needed into interventions to reduce 
inequalities in vaccine uptake during pregnancy,36 to 
ensure that future vaccine promotion of these and any 
future maternal vaccination programmes succeed in 
narrowing rather than widening the large and multi- 
faceted health inequalities in early years.
Twitter Helen I McDonald @ehr_lshtm
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